CompletedNCT00043329
Post Marketing Surveillance Study of Actimmune in Patients With Severe, Malignant Osteopetrosis
Studying Albers-Schönberg osteopetrosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- InterMune
- Principal Investigator
- Steven Porter, MD, D.D.SInterMune
- Intervention
- Actimmune Registry(drug)
- Enrollment
- 6 enrolled
- Eligibility
- All sexes
- Timeline
- 2002 – 2005
Study locations (1)
- InterMune, Inc., Brisbane, California, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00043329 on ClinicalTrials.gov